25 Tribal Organizations, Medical Schools and Others to Advocate for Policies that Empower New Physicians to Practice in Tribal Communities. Today, 25 urban and rural Tribal organizations, medical schools, health plans, teaching hospitals, medical residencies, and physician advocates launched the American Indian Medical Education Strategies (AIMES) Alliance. The AIMES Alliance, whose mission is to address … Read more
Pharmacy provision of clinical services is important to patient access and outcomes. As patients access more services from pharmacies, the data interoperability of those pharmacies becomes more important to the healthcare system at-large. Pharmacy teams’ ability to provide optimal care and meaningfully contribute to the value-based care transformation depends on their ability to access and … Read more
Supporting Pharmacy Data Interoperability: An Imperative for Patient Access and Outcomes Featured Experts
Consumer health app developers are finding ways to help consumers and their physicians make better use of their health data. These apps can now get accredited for their compliance with best practices in managing personal health information, an important step towards building trust that consumers’ health data will be protected as it is moved more … Read more
Partnership Calls on Policymakers to Implement Proposals in 2020 Landmark Report Washington, D.C. — In recognition of World Sickle Cell Day on June 19th, today more than a dozen organizations representing a diverse cross-section of patient advocates, health professional organizations, health insurers and biopharmaceutical companies announced the launch of the Sickle Cell Disease Partnership. The … Read more
As respiratory syncytial virus (RSV), a seasonal pathogen in young children is challenging the national health care system as part of an unprecedented “tripledemic” with COVID-19 and flu this winter, authors with Leavitt Partners parent company Health Management Associates weigh in on potential coverage pathways for new monoclonal antibody (mAb) preventive therapies for RSV and … Read more
Salt Lake City, March 16, 2021—Today, Leavitt Partners released “Using Modeling to Project Herd Immunity: When and how we will get back to normal,” a research paper outlining results from their current model to determine the expected timeline to reaching herd immunity from COVID-19. The research was conducted in response to growing interest in understanding … Read more
Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Read more
Salt Lake City, May 14, 2020 –Today, the American Journal of Managed Care (AJMC) released an article entitled “Accountable Care Organizations Are Increasingly Led by Physician Groups Rather Than Hospital Systems.” This article outlines the shift in accountable care organization (ACO) market leadership as physician group organizations have begun to lead the majority of new … Read more
Salt Lake City, May 12, 2020 – New analysis from Leavitt Partners and CareJourney explores ways in which accountable care organizations (ACOs) can reduce health care costs without potentially impacting their beneficiaries’ quality of care. One such opportunity for ACOs lies in switching patients to similarly effective but less-expensive medications for particular conditions. Our analysis … Read more
